The Pipeline

Home>News>The Pipeline

Peter MacCallum Cancer Centre and Cartherics Announce Collaboration to Develop Autologous CAR-T Cell Therapy for Cutaneous T-Cell Lymphoma

Melbourne, Victoria, Australia – 08 November 2022

The Peter MacCallum Cancer Centre (“Peter Mac”) and Cartherics Pty Ltd (“Cartherics”) announced today they have entered into a Collaborative Development Program Agreement (CDPA) to develop Cartherics’ proprietary autologous CAR-T cell therapy (CTH-001) for the treatment of cutaneous T-cell lymphoma (CTCL).

“Patients with advanced stages of cutaneous T-cell lymphomas often […]

2022-11-09T10:04:56+11:00November 8th, 2022|

Cartherics is ‘Frocking Up’ this month in support of ovarian cancer research

Cartherics is delighted to be participating in Frocktober – Australia’s most fashionable month-long fundraiser to raise awareness and funds for vital ovarian cancer research through the Ovarian Cancer Research Foundation (OCRF).

Ovarian cancer is Australia’s most lethal gynaecological cancer, taking more than 1,000 lives each year. With a five-year survival rate of only 48%, there […]

2022-10-17T11:29:29+11:00October 17th, 2022|

Cartherics unveils new $4M lab to develop cancer immunotherapy treatments in Victoria

MELBOURNE, Australia, 13 October 2022 – Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, has opened today a brand-new state-of-the-art facility to strengthen the company’s research and manufacturing capabilities, as well as support local innovation. Cartherics invested AU$4M in the newly designed and built facility, which includes PC2 and dedicated […]

2022-11-09T12:37:54+11:00October 13th, 2022|

Cartherics granted first US patent for multiple development candidates

Melbourne, Australia, 06 October 2022Cartherics, a biotechnology company developing immune cell therapies for the treatment of cancer, announced today that it has been granted US patent 11,400,145, entitled “Genetically modified cells and uses thereof”.

This patent provides a proprietary position for multiple development candidates in Cartherics’ pipeline. Specifically, this patent covers Cartherics’ chimeric […]

2022-10-06T13:32:10+11:00October 6th, 2022|

3 Cheers for a Cartherics Board Member

Bryan Williams ranked among the world’s most prominent scientists

By Leigh Dayton, 16 June 2022

Cartherics is delighted to announce that Non-Executive Director Bryan Williams is one of the top 1000 scientists worldwide in the field of Genetics and Molecular Biology, according to Research.com, a prominent academic platform for scientists.

In the recently released edition its […]

2022-06-16T09:19:26+10:00June 16th, 2022|

She’s an Adventurer, Advocate, Author and a Cancer Survivor

Now Heather Hawkins is a member of the Cartherics Board

By Leigh Dayton  9 June 2022

It’s official. As of this month, ovarian cancer campaigner Heather Hawkins takes up her role as an Advisory Board Member for Cartherics.

“It’s a privilege and an honour to be part of the Board,” she says. “And I’m looking forward to assisting […]

2022-06-09T14:44:04+10:00June 9th, 2022|

Presentation: Multi-Functional Cell Therapies Summit

Chief Development Officer, Dr Nicholas Boyd

Cell therapies have the potential to not only be life-saving but curative for a host of diseases. However, inherent limitations in autologous based CAR-T therapy face major roadblocks for mass adoption and therapeutic effects in solid tumour indications.

On Friday 28 January at 7:30 am AEDT Nicholas will discuss the design, […]

2022-01-27T16:58:33+11:00January 27th, 2022|

‘Off-the-Shelf’ Immunotherapy Gets Special Treatment in Special Issue of The Journal Cells

Thanks go to Special Editor, Cartherics CEO Alan Trounson

By Leigh Dayton, 17 January 2022

Cellular immunotherapy is revolutionizing cancer treatment, and off-the-shelf or allogeneic, treatments are beginning to replace technologies developed individually for each patient.

This is good news because the potential of allogeneic therapies is great. They promise to significantly save time and cut costs compared […]

2022-01-17T09:29:18+11:00January 17th, 2022|

A Star is Born! Cartherics student takes out top award …..

By Leigh Dayton,  4 January 2022

When Cartherics Biomedical Honours student Elizabeth (Liz) Bakaniozos opened an e-mail this month from the Director and CEO of Monash University’s Hudson Institute of Medical Research she was “really surprised and grateful”.

And rightly so. Elizabeth Hartland wrote to advise and congratulate Liz on winning the Hudson Institute Lois Salamonsen Honours […]

2022-01-04T12:17:29+11:00January 4th, 2022|

Three Cheers for the CARTeam!

By Leigh Dayton, 6 December 2021

When eight Cartherics women first teamed-up to walk or run 4km every day in November and raise funds to support women living with ovarian cancer, they set what they believed were achievable goals. The newly minted CARTeam would collectively move 120 km and raise $500.

They sorely misjudged their efforts. Despite […]

2021-12-06T20:42:53+11:00December 6th, 2021|
Go to Top